IT1255723B - Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione - Google Patents

Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Info

Publication number
IT1255723B
IT1255723B ITMI922331A ITMI922331A IT1255723B IT 1255723 B IT1255723 B IT 1255723B IT MI922331 A ITMI922331 A IT MI922331A IT MI922331 A ITMI922331 A IT MI922331A IT 1255723 B IT1255723 B IT 1255723B
Authority
IT
Italy
Prior art keywords
gestation
abortion
therapy
prevention
treatment
Prior art date
Application number
ITMI922331A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITMI922331A0 publication Critical patent/ITMI922331A0/it
Priority to ITMI922331A priority Critical patent/IT1255723B/it
Priority to EP93922531A priority patent/EP0663835B1/en
Priority to PCT/EP1993/002755 priority patent/WO1994008613A2/en
Priority to US08/411,726 priority patent/US5880093A/en
Priority to DE69310528T priority patent/DE69310528T2/de
Priority to ES93922531T priority patent/ES2103493T3/es
Priority to KR1019950701350A priority patent/KR100293846B1/ko
Priority to DK93922531.4T priority patent/DK0663835T3/da
Priority to AT93922531T priority patent/ATE152628T1/de
Priority to AU51499/93A priority patent/AU680631B2/en
Priority to NZ256679A priority patent/NZ256679A/en
Priority to JP6509588A priority patent/JPH08502271A/ja
Priority to CA002146666A priority patent/CA2146666A1/en
Publication of ITMI922331A1 publication Critical patent/ITMI922331A1/it
Priority to NO19951050A priority patent/NO317930B1/no
Application granted granted Critical
Publication of IT1255723B publication Critical patent/IT1255723B/it
Priority to GR970401802T priority patent/GR3024157T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Sono descritte composizioni farmaceutiche contenenti come principio attivo Paratormone, suoi frammenti biologicamente attivi e peptidi correlati (PTHrP), eventualmente in combinazione con gli opportuni additivi farmaceuticamente accettabili, utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione.
ITMI922331A 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione IT1255723B (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
AT93922531T ATE152628T1 (de) 1992-10-09 1993-10-08 Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
NZ256679A NZ256679A (en) 1992-10-09 1993-10-08 Use of parathormone (parathyroid hormone) in prevention and therapy of abortion and of premature birth
US08/411,726 US5880093A (en) 1992-10-09 1993-10-08 Use of parathormone, its biologically active fragments and correlated peptides, for the preparation of pharmaceutical compositions useful for the treatment of pregnancy
DE69310528T DE69310528T2 (de) 1992-10-09 1993-10-08 Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ES93922531T ES2103493T3 (es) 1992-10-09 1993-10-08 Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
KR1019950701350A KR100293846B1 (ko) 1992-10-09 1993-10-08 임신치료를위한파라소먼,그생물학적활성프래그먼트및관련펩티드의용도
DK93922531.4T DK0663835T3 (da) 1992-10-09 1993-10-08 Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet
EP93922531A EP0663835B1 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
AU51499/93A AU680631B2 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
PCT/EP1993/002755 WO1994008613A2 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
JP6509588A JPH08502271A (ja) 1992-10-09 1993-10-08 パラトルモン、その生物学的活性フラグメント及び関連ペプチドの妊娠時の治療への使用
CA002146666A CA2146666A1 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
NO19951050A NO317930B1 (no) 1992-10-09 1995-03-20 Anvendelse av paratyroidhormon, dets biologisk aktive fragmenter og korrelerte peptider for fremstilling av farmasoytiske blandinger for behandling under svangerskap.
GR970401802T GR3024157T3 (en) 1992-10-09 1997-07-17 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Publications (3)

Publication Number Publication Date
ITMI922331A0 ITMI922331A0 (it) 1992-10-09
ITMI922331A1 ITMI922331A1 (it) 1994-04-09
IT1255723B true IT1255723B (it) 1995-11-13

Family

ID=11364090

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Country Status (14)

Country Link
US (1) US5880093A (it)
EP (1) EP0663835B1 (it)
JP (1) JPH08502271A (it)
KR (1) KR100293846B1 (it)
AT (1) ATE152628T1 (it)
AU (1) AU680631B2 (it)
CA (1) CA2146666A1 (it)
DE (1) DE69310528T2 (it)
DK (1) DK0663835T3 (it)
ES (1) ES2103493T3 (it)
GR (1) GR3024157T3 (it)
IT (1) IT1255723B (it)
NZ (1) NZ256679A (it)
WO (1) WO1994008613A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
ATE363289T1 (de) * 1995-02-20 2007-06-15 Yukio Kato Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US6043981A (en) * 1997-11-13 2000-03-28 Chrysler Corporation Heat sink assembly for electrical components
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
ZA9811127B (en) † 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
JP4486256B2 (ja) * 1998-10-22 2010-06-23 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
AU2002339843B2 (en) * 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
WO2004067021A1 (en) * 2003-01-24 2004-08-12 Gardella Thomas J Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
US7795220B2 (en) * 2003-03-19 2010-09-14 The General Hospital Corporation Conformationally constrained parathyroid hormones with alpha-helix stabilizers
JP4871128B2 (ja) 2003-07-17 2012-02-08 ザ ジェネラル ホスピタル コーポレイション 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ
US7556821B2 (en) 2004-05-13 2009-07-07 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2005116056A1 (ja) * 2004-05-26 2005-12-08 Green Peptide Co., Ltd. 副甲状腺ホルモン関連タンパク質のhla-a24またはhla-a2結合ペプチド
WO2008019062A2 (en) * 2006-08-04 2008-02-14 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
CN104072606B (zh) * 2007-08-01 2017-09-22 总医院有限公司 利用g蛋白偶联受体和相关组合物的筛选方法
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
ES2129048T3 (es) * 1991-12-09 1999-06-01 Asahi Chemical Ind Composicion estabilizada de hormona paratiroide.
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone

Also Published As

Publication number Publication date
DE69310528D1 (de) 1997-06-12
US5880093A (en) 1999-03-09
AU5149993A (en) 1994-05-09
DK0663835T3 (da) 1997-09-01
ITMI922331A1 (it) 1994-04-09
KR950703359A (ko) 1995-09-20
JPH08502271A (ja) 1996-03-12
WO1994008613A3 (en) 1994-05-26
CA2146666A1 (en) 1994-04-28
DE69310528T2 (de) 1997-09-11
EP0663835A1 (en) 1995-07-26
ATE152628T1 (de) 1997-05-15
AU680631B2 (en) 1997-08-07
GR3024157T3 (en) 1997-10-31
ITMI922331A0 (it) 1992-10-09
NZ256679A (en) 1997-03-24
ES2103493T3 (es) 1997-09-16
KR100293846B1 (ko) 2001-09-17
EP0663835B1 (en) 1997-05-07
WO1994008613A2 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
IT1255723B (it) Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
AP1637A (en) Celecoxib compositions.
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
MY119365A (en) Novel pharmaceutical combination
HUP9801591A3 (en) Use of nitric oxide-releasing agents for producing pharmaceutical composition to treat impotency, and delivery device dosage of nitric oxide
CA2302700A1 (en) New use for budesonide and formoterol
SG1893G (en) Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
MX173567B (es) Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih
PT639979E (pt) Ligando para o receptor c-kit e metodos para a sua utilizacao
EP0177342A3 (en) Oral formulation of therapeutic proteins
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
AU5323396A (en) Methods of treating inflammation and compositions therefor
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
AU8687391A (en) Lithium treatment
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
YU56702A (sh) Korišćenje fsh za lečenje neplodnosti
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
EG17992A (en) Preparation of a medicament for arthritis and theumatism
MY104088A (en) Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030